• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION COREVALVE TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION COREVALVE TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number CRS
Device Problems Gradient Increase (1270); Perivalvular Leak (1457)
Patient Problems Aortic Regurgitation (1716); Non specific EKG/ECG Changes (1817); Insufficiency, Valvular (1926); Unspecified Infection (1930); Neurological Deficit/Dysfunction (1982); Sepsis (2067); Tissue Damage (2104); Cardiac Tamponade (2226); Blood Loss (2597); Pseudoaneurysm (2605)
Event Date 04/29/2019
Event Type  Injury  
Manufacturer Narrative
Citation: seppelt pc et al.Aortic valve replacement in patients with preexisting liver disease: transfemoral approach with favorable survival.Catheter cardiovasc interv.2020 jan;95(1):54-64.Doi: 10.1002/ccd.28319.Epub 2019 apr 29.Earliest date of publish used for event date.No unique device identifier (serial/lot) numbers were provided; without this information it could not be determined whether these observations have been previously reported.Without return of the product no definitive conclusion can be made regarding the clinical observations.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information via literature regarding the outcomes of patients with pre-existing liver disease who underwent surgical aortic valve replacement or transcatheter aortic valve replacement (tavr) through the transapical (ta-tavr) or transfemoral (tf-tavr) routes.All data were retrospectively collected from a single center between january 2004 and august 2016.The overall study population included 85 patients and was predominantly male with a mean age of 73 years.The tf-tavr subgroup comprised 30 patients and 5 of those were implanted with medtronic corevalve transcatheter bioprosthetic valves.No serial numbers were provided.For the overall study population, the most known causes of death were reported to be sepsis, major bleeding, and low cardiac output/ multi-organ failure/acute liver failure.Among all tf-tavr patients, 5 deaths occurred within one-year of the procedure.Multiple manufacturers transcatheter valves were involved in the tf-tavr subgroup, and based on the available information, medtronic product was not directly associated with the deaths.Among all tf-tavr patients, adverse events included: post-procedural permanent pacemaker implantation; reoperation due to severe bleeding; intra-procedural extracorporeal membrane oxygenation support; gastrointestinal complications (bleeding, subileus, or ileus); sepsis; unspecified infection; unspecified neurological events; major adverse cardiac events; post-procedural percutaneous coronary intervention; aneurysma spurium (pseudoaneurysm); severe aortic insufficiency or paravalvular leak; pericardial tamponade; and high aortic valve gradients.Based on the available information, medtronic product may have been associated with the adverse events.No additional adverse patient effects or product performance issues were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COREVALVE TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key9794902
MDR Text Key182596752
Report Number2025587-2020-00688
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Physician
Type of Report Initial
Report Date 03/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberCRS
Device Catalogue NumberCRS
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2020
Initial Date FDA Received03/05/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-